Related Experiment Video
Updated: Oct 30, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Emergent Pneumonia in Children
Cecilia Perret1, Nicole Le Corre1, Jose A Castro-Rodriguez2
1Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Insights
Emerging pathogens cause pneumonia in adults and children. This review classifies these pathogens as true emerging, re-emerging, or old known with new presentations, aiding in diagnosis and treatment.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Pneumonia is increasingly caused by emerging pathogens in both adults and children.
- Understanding these pathogens is crucial for effective public health strategies.
- This article categorizes emerging pathogens for clarity.
Purpose of the Study:
- To classify emerging pneumonia pathogens affecting humans.
- To compare the epidemiology, presentation, therapy, and prognosis in children versus adults.
- To facilitate recognition, appropriate treatment, and control of emerging infectious diseases.
Main Methods:
- Classification of pathogens into three categories: true emerging, re-emerging, and old known with new presentations.
- Review of epidemiological data, clinical presentations, therapeutic approaches, and prognoses.
- Comparative analysis between pediatric and adult populations.
Main Results:
- Identified "true emerging" pathogens (e.g., SARS-CoV-2, MERS-CoV, avian influenza).
- Detailed "re-emerging" pathogens (e.g., measles, tuberculosis, resistant bacteria like CA-MRSA, Mycoplasma pneumoniae).
- Highlighted "old known with new presentations" (e.g., rhinovirus, non-SARS coronaviruses).
Conclusions:
- Accurate classification aids in understanding the evolving landscape of pneumonia-causing pathogens.
- Recognizing differences in presentation and prognosis between children and adults is vital.
- Effective control measures and targeted therapies depend on timely pathogen identification.
Abstract:
In recent decades there have been multiple pathogens, viruses and bacteria, which have emerged as causal agents of pneumonia affecting adults, albeit less frequently, to children. For the purposes of this article we have classified emerging pathogens as follows: True emerging, to pathogens identified for the very first time affecting human population (SARS-CoV-1, SARS-CoV-2, MERS-CoV, avian influenza, and hantavirus); Re-emerging, to known pathogens which circulation was controlled once, but they have reappeared (measles, tuberculosis, antimicrobial resistant bacteria such as CA-MRSA, Mycoplasma pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and new serotypes of post-vaccine pneumococcal); and finally, those that we have called old known with new presentations, including common pathogens that, in particular condition, have changed their form of presentation (rhinovirus, and non-SARS coronavirus). We will review for each of them their epidemiology, forms of presentation, therapy, and prognosis in children compared to the adult with the aim of being able to recognize them to establish appropriate therapy, prognostics, and effective control measures.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Cycle: Exhalation